Fuji Pharma Co Ltd (4554)

Tokyo

Currency in JPY

1,467.0

+5.0(+0.34%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

1,457.0

1,475.0

52 wk Range

1,180.0

1,643.0

4554 Income Statement

Featured here, the Income Statement (earnings report) for Fuji Pharma Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2015

30/09

2016

30/09

2017

30/09

2018

30/09

2019

30/09

2020

30/09

2021

30/09

2022

30/09

2023

30/09

2024

30/09

Total Revenues

aa.aa

33,793

33,990

35,426

40,889

46,138

Total Revenues Growth

aa.aa

-6.85%

+0.58%

+4.22%

+15.42%

+12.84%

Cost Of Revenues

aa.aa

18,921

19,239

20,867

24,374

28,294

Gross Profit

aa.aa

14,872

14,751

14,559

16,515

17,844

Gross Profit Growth

aa.aa

-5.85%

-0.81%

-1.3%

+13.43%

+8.05%

Gross Profit Margin %

aa.aa

44.01%

43.4%

41.1%

40.39%

38.68%

Other Operating Expenses, Total

aa.aa

11,732

11,402

10,781

12,656

13,963

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+0.95%	-2.81%	-5.45%	+17.39%	+10.33%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3,060	2,446	2,485	3,184	3,401
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,048	8,340	7,355	8,331	9,231
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

3,140

3,349

3,778

3,859

3,881

Operating Income Growth

aa.aa

-24.77%

+6.66%

+12.81%

+2.14%

+0.57%

EBIT Margin %

aa.aa

9.29%

9.85%

10.66%

9.44%

8.41%

Net Interest Expenses

aa.aa

-37

-46

-34

-44

-196

Net Interest Expenses Growth

aa.aa

+9.76%

-24.32%

+26.09%

-29.41%

-345.45%

Interest Expense, Total

aa.aa

-37

-53

-77

-121

-196

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-121

-54

266

339

127

EBT, Excl. Unusual Items

aa.aa

2,982

3,249

4,010

4,154

3,812

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-69

-34

-288

244

1,344

EBT, Incl. Unusual Items

aa.aa

2,917

3,370

3,722

4,398

8,274

EBT, Incl. Unusual Items Growth

aa.aa

-26.34%

+15.53%

+10.45%

+18.16%

+88.13%

EBT, Incl. Unusual Items Margin

aa.aa

8.63%

9.91%

10.51%

10.76%

17.93%

Income Tax Expense

aa.aa

832

938

1,026

963

2,128

Net Income to Company

aa.aa

2,085

2,432

2,696

3,435

6,146

Minority Interest

aa.aa

Net Income

aa.aa

2,085

2,432

2,696

3,435

6,146

Net Income Growth

aa.aa

-29.61%

+16.64%

+10.86%

+27.41%

+78.92%

Net Income Margin %

aa.aa

6.17%

7.16%

7.61%

8.4%

13.32%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

2,085

2,432

2,696

3,435

6,146

Basic EPS - Continuing Operations

aa.aa

66.92

90.52

110.98

141.35

252.81

Basic EPS - Continuing Operations Growth

aa.aa

-31.03%

+35.27%

+22.6%

+27.37%

+78.85%

Diluted EPS - Continuing Operations

aa.aa

66.92

90.52

110.98

141.35

252.81

Diluted EPS - Continuing Operations Growth

aa.aa

-31.03%

+35.27%

+22.6%

+27.37%

+78.85%

Basic Weighted Average Shares Outstanding

aa.aa

31.16

26.87

24.29

24.3

24.31

Diluted Weighted Average Shares Outstanding

aa.aa

31.16

26.87

24.29

24.3

24.31

Dividend Per Share

aa.aa

42.5

Dividend Per Share Growth

aa.aa

+20.69%

+5.71%

+14.86%

EBITDA

aa.aa

5,197

5,455

6,523

6,882

7,561

EBITDA Growth

aa.aa

-17.55%

+4.96%

+19.58%

+5.5%

+9.87%

EBITDA Margin %

aa.aa

15.38%

16.05%

18.41%

16.83%

16.39%

EBIT

aa.aa

3,140

3,349

3,778

3,859

3,881

* In Millions of JPY (except for per share items)

NSE 30

5,165.05

-34.47

-0.66%

NSE All Share

141,566.28

-1,047.19

-0.73%

US 30

44,816.50

-121.6

-0.27%

US 500

6,388.90

-6.9

-0.11%

FTSE 100

9,279.80

-8.34

-0.09%

DAX

24,257.10

-20.00

-0.08%

South Africa Top 40

93,997.30

+505.35

+0.54%

Market Movers

Name	Last	Chg. %	Vol.
Champion Brew	19.74	+9.97%	54.52M
Access Holdings	27.40	-0.18%	18.85M
Zenith Bank	68.00	+1.42%	18.31M
UBA	48.00	0.00%	12.87M
Guaranty Trust Holding	90.15	-5.11%	10.16M
STANBIC IBTC Bank	95.00	-2.46%	8.14M
MTN Nigeria	445.00	0.00%	3.02M

Name	Last	Chg. %	Vol.
Austin Laz	2.64	+10.00%	1.24M
Champion Brew	19.74	+9.97%	54.52M
Ncr Nigeria	9.55	+9.77%	113.00K
Multverse	11.10	+8.82%	1.60M
Nigerian Enamelware PLC	39.00	+8.64%	643.85K
Daarcomm	1.30	+5.69%	6.86M
Afriprud	15.90	+5.30%	5.94M

Name	Last	Chg. %	Vol.
Conoil	211.10	-9.98%	471.09K
Guinness Nigeria	140.20	-9.98%	243.57K
Consolidated Hallmark	4.35	-9.94%	3.77M
Royalex	2.27	-9.92%	46.15M
Ellah Lakes	14.90	-9.81%	11.93M
Sovereign Trust Insurance Plc	2.67	-9.80%	15.13M
Deap Capital Management Trust	1.75	-9.79%	13.65M

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	3.94	-8.37%	39.28M
Mutual Benefits Assurance	4.05	-5.81%	33.68M
Ellah Lakes	14.90	-9.81%	11.93M
Presco	1,480.00	0.00%	160.42K
Zenith Bank	68.00	+1.42%	18.31M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaa	5,379.30	+52.02%	8,177.61
Aaaaaaaaaaa	1,890.00	+41.79%	2,679.83
Aaaaaa Aa	520.00	+41.33%	734.92
Aaaa Aaaaa	64.10	+31.86%	84.52
Aaaaaaaa A Aaaaaaa	168.60	+26.06%	212.54
Aaaaaaaaaaaaaaaaaa A	640.00	+14.66%	733.82

Name	Last	Upside	Fair Value
Aaa Aaa	5,379.30	+52.02%	8,177.61
Aaaaaaaaaaa	1,890.00	+41.79%	2,679.83
Aaaaaa Aa	520.00	+41.33%	734.92
Aaaa Aaaaa	64.10	+31.86%	84.52
Aaaaaaaa A Aaaaaaa	168.60	+26.06%	212.54
Aaaaaaaaaaaaaaaaaa A	640.00	+14.66%	733.82

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Fuji Pharma Co Ltd (4554)

4554 Income Statement

Trending Stocks